Furthermore, upregulated GSN may suppress cancer cell proliferation and metastasis for glioblastoma and myelodysplastic syndrome (MDS) (Zhang et al., 2020a; Deng et al., 2020). This evidence concerns the gene GSN and myelodysplastic syndrome.